IL22 and Alzheimer disease: IL-22 could inhibit epidermal differentiation and promote inflammation in AD skin lesions by inducing the secretion of IL-6, and downregulate the expression of keratinocyte fibril aggregation proteins in keratinocytes, especially, to increase the degree of epidermal damage (168), which is closely related to the severity of AD.